Erythrocyte N-3 is inversely correlated with serious psychological distress among the inuit: Data from the nunavik health survey

Journal of the American College of Nutrition

Volumn 29, Issue 3, 2010, Pages 211-221

  Lucas, Michel ^a   Kirmayer, Laurence J ^b   Déry, Serge ^c   Dewailly, Éric ^a,c  

^a LAVAL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

Inuit; K6; Omega 3 and omega 6 fatty acids; Psychological distress; RBCs

Indexed keywords

LONG CHAIN FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ADULT; ARTICLE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISTRESS SYNDROME; ERYTHROCYTE MEMBRANE; FEMALE; HEALTH SURVEY; HUMAN; KESSLER 6 ITEM SCALE; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PREVALENCE; RISK FACTOR; SCREENING TEST;

ADULT; DEPRESSION; ERYTHROCYTES; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HEALTH SURVEYS; HUMANS; INUITS; LOGISTIC MODELS; MALE; ODDS RATIO; PREVALENCE; QUEBEC; STRESS, PSYCHOLOGICAL;

EID: 77957909098     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2010.10719836     Document Type: Article

References (72)

1. Murray CJL, Lopez AD: Alternative visions of the future: projecting mortality and disability, 1990–2020. In Murray CJL, Lopez AD (eds): “The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020.” Boston: Harvard University Press, pp 325–397, 1996.
2. Kirmayer LJ, Brass GM, Tait CL: The mental health of Aboriginal peoples: transformations of identity and community. Can J Psychiatry 45:607–616, 2000.
3. Haggarty J, Cernovsky Z, Kermeen P, Merskey H: Psychiatric disorders in an Arctic community. Can J Psychiatry 45:357–362, 2000.
4. McGrath-Hanna NK, Greene DM, Tavernier RJ, Bult-Ito A: Diet and mental health in the Arctic: is diet an important risk factor for mental health in circumpolar peoples? A review. Int J Circumpolar Health 62:228–241, 2003.
5. Santé-Québec: “A Health Profile of the Inuit: Report of the Santé-Québec Health Survey Among the Inuit of Nunavik, 1992,” vols 1 and 2. Montréal, Canada: Ministere de la Santé et des Services sociaux, Gouvernement du Québec, 1994.
6. Blanchet C, Dewailly E, Ayotte P, Bruneau S, Receveur O, Holub B: Contribution of selected traditional and market foods to the diet of Nunavik Inuit women. Can J Diet Pract Res 61:50–59, 2000.
7. Dewailly E, Blanchet C, Lemieux S, Sauvé L, Gingras S, Ayotte P, Holub B: N-3 fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik. Am J Clin Nutr 74:464–473, 2001.
8. Simopoulos AP: The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 56:365–379, 2002.
9. Blanchet C, Rochette L: “Nutrition and food consumption among the Inuit of Nunavik. Nunavik Inuit Health Survey 2004, Qanuippitaa? How are we?” Quebec, Canada: Institut national de santé publique du Québec (INSPQ) & Nunavik Regional Board of Health and Social Services (NRBHSS), 2004. Accessed October 2008 at: http://www.inspq.qc.ca
10. Hibbeln JR, Salem N Jr: Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr 62:1–9, 1995.
11. Bruinsma KA, Taren DL: Dieting, essential fatty acid intake, and depression. Nutr Rev 58:98–108, 2000.
12. Simopoulos AP: Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother 60:502–507, 2006.
13. Yehuda S, Rabinovitz S, Mostofsky DI: Essential fatty acids are mediators of brain biochemistry and cognitive functions. J Neurosci Res 56:565–570, 1999.
14. Serhan CN: Novel omega-3 derived local mediators in antiinflammation and resolution. Pharmacol Ther 105:7–21, 2005.
15. Farooqui AA, Horrocks LA, Farooqui T: Modulation of inflammation in brain: a matter of fat. J Neurochem 101:577–599, 2007.
16. Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, Peet M, Keck PE, Marangell LB, Richardson AJ, Lake J, Stoll AL: Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 67:1954–1067, 2006.
17. Lucas M, Dewailly E, Blanchet B, Gingras S, Holub BJ: Plasma omega-3 and psychological distress among Nunavik Inuit (Canada). Psychiatry Res 167:266–278, 2009.
18. Kessler RC, Ustun TB: The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res 13:93–121, 2004.
19. Kessler RC, Andrews G, Colpe LJ, Hiripi E, Mroczek DK, Normand SL, Walters EE, Zaslavsky AM: Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med 32:959–976, 2002.
20. Kessler RC, Barker PR, Colpe LJ, Epstein JF, Gfroerer JC, Hiripi E, Howes MJ, Normand SL, Manderscheid RW, Walters EE, Zaslavsky AM: Screening for serious mental illness in the general population. Arch Gen Psychiatry 60:184–189, 2003.
21. Furukawa TA, Kessler RC, Slade T, Andrews G: The performance of the K6 and K10 screening scales for psychological distress in the Australian National Survey of Mental Health and Well-Being. Psychol Med 33:357–362, 2003.
22. Cairney J, Veldhuizen S, Wade TJ, Kurdyak P, Streiner DL: Evaluation of 2 measures of psychological distress as screeners for depression in the general population. Can J Psychiatry 52:111-120, 2007.
23. Shaikh NA, Downar E: Time course of changes in porcine myocardial phospholipid levels during ischemia: a reassessment of the lysolipid hypothesis. Circ Res 49:316–325, 1981.
24. Lepage G, Roy CC: Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 27:114–120, 1986.
25. Health Canada: “Canadian Nutrient File.” Ottawa: Health Canada, 2005. Accessed October 2006 at: http://www.hc-sc.gc.ca/fn-an/nutrition/fiche-nutri-data/index_e.html
26. U.S. Department of Agriculture, Agricultural Research Service, 2002: “USDA National Nutrient Database for Standard Reference,” Release 15. Accessed June 2008 at: http://www.ars.usda.gov
27. Willett WC: “Nutritional Epidemiology,” 2nd ed. New York: Oxford University Press, 1998.
28. Babyak MA: What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med 66:411–421, 2004.
29. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR: A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49:1373–1379, 1996.
30. Steyerberg EW, Eijkemans MJ, Harrell FE Jr, Habbema JD: Prognostic modeling with logistic regression analysis: in search of a sensible strategy in small data sets. Med Decis Making 21:45-56, 2001.
31. Pratt LA, Dey AN, Cohen AJ: Characteristics of adults with serious psychological distress as measured by the K6 scale: United States, 2001–04. Adv Data 382:1–18, 2007.
32. Barnes PM, Adams PF, Powell-Griner E: Health characteristics of the Asian adult population: United States, 2004–2006. Adv Data 394:1–22, 2008.
33. Shih M, Simon PA: Health-related quality of life among adults with serious psychological distress and chronic medical conditions. Qual Life Res 17:521–528, 2008.
34. Boothroyd LJ, Kirmayer LJ, Spreng S, Malus M, Hodgins S: Completed suicides among the Inuit of northern Quebec, 1982-1996: a case-control study. CMAJ 165:749–755, 2001.
35. Edwards R, Peet M, Shay J, Horrobin D: Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 48:149–155, 1998.
36. Peet M, Murphy B, Shay J, Horrobin D: Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 43:315–319, 1998.
37. Adams PB, Lawson S, Sanigorski A, Sinclair AJ: Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 31:S157–S161, 1996.
38. Feart C, Peuchant E, Letenneur L, Samieri C, Montagnier D, Fourrier-Reglat A, Barberger-Gateau P: Plasma eicosapentaenoic acid is inversely associated with severity of depressive symptomatology in the elderly: data from the Bordeaux sample of the Three-City Study. Am J Clin Nutr 87:1156–1162, 2008.
39. Timonen M, Horrobin D, Jokelainen J, Laitinen J, Herva A, Rasanen P: Fish consumption and depression: the Northern Finland 1966 birth cohort study. J Affect Disord 82:447–452, 2004.
40. Tanskanen A, Hibbeln JR, Tuomilehto J, Uutela A, Haukkala A, Viinamaki H, Lehtonen J, Vartiainen E: Fish consumption and depressive symptoms in the general population in Finland. Psychiatr Serv 52:529–531, 2001.
41. Kamphuis MH, Geerlings MI, Tijhuis MA, Kalmijn S, Grobbee DE, Kromhout D: Depression and cardiovascular mortality: a role for n-3 fatty acids? Am J Clin Nutr 84:1513–1517, 2006.
42. Hakkarainen R, Partonen T, Haukka J, Virtamo J, Albanes D, Lonnqvist J: Is low dietary intake of omega-3 fatty acids associated with depression? Am J Psychiatry 161:567–569, 2004.
43. Sanchez-Villegas A, Henriquez P, Figueiras A, Ortuno F, Lahortiga F, Martinez-Gonzalez MA: Long chain omega-3 fatty acids intake, fish consumption and mental disorders in the SUN cohort study. Eur J Nutr 46:337–346, 2007.
44. Kobayashi M, Sasaki S, Kawabata T, Hasegawa K, Akabane M, Tsugane S: Single measurement of serum phospholipid fatty acid as a biomarker of specific fatty acid intake in middle-aged Japanese men. Eur J Clin Nutr 55:643–650, 2001.
45. Hebert JR, Ma Y, Clemow L, Ockene IS, Saperia G, Stanek EJ, Merriam PA, Ockene JK: Gender differences in social desirability and social approval bias in dietary self-report. Am J Epidemiol 146:1046–1055, 1997.
46. Katan MB, Deslypere JP, van Birgelen APJM, Penders M, Zegwaard M: Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res 38:2012–2022, 1997.
47. Kidd PM: Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev 12:207–227, 2007.
48. Stahl LA, Begg DP, Weisinger RS, Sinclair AJ: The role of omega-3 fatty acids in mood disorders. Curr Opin Investig Drugs 9:57–64, 2008.
49. Brown AJ, Pang E, Roberts DC: Persistent changes in the fatty acid composition of erythrocyte membranes after moderate intake of n-3 polyunsaturated fatty acids: study design implications. Am J Clin Nutr 54:668–673, 1991.
50. Arterburn LM, Hall EB, Oken H: Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 83:1467S–1476S, 2006.
51. Brown AJ, Pang E, Roberts DCK: Erythrocyte eicosapentaenoic acid versus docosahexaenoic acid as a marker for fish and fish oil consumption. Prostaglandins Leukot Essent Fatty Acids 44:103-106, 1991.
52. Harris WS, Von Schacky C: The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med 39:212–220, 2004.
53. Kiecolt-Glaser JK, Belury MA, Porter K, Beversdorf DQ, Lemeshow S, Glaser R: Depressive symptoms, omega-6:omega-3 fatty acids, and inflammation in older adults. Psychosom Med 69:217–224, 2007.
54. Maes M, Christophe A, Bosmans E, Lin A, Neels H: In humans, serum polyunsaturated fatty acid levels predict the response of proinflammatory cytokines to psychologic stress. Biol Psychiatry 47:910–920, 2000.
55. Harris WS: The omega-6/omega-3 ratio and cardiovascular disease risk: uses and abuses. Curr Atheroscler Rep 8:453–459, 2006.
56. Arab L: Biomarkers of fat and fatty acid intake. J Nutr 133(suppl 3):925S–932S, 2003.
57. Plourde M, Cunnane S: Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab 32:619–634, 2007.
58. Goyens PL, Spilker ME, Zock PL, Katan MB, Mensink RP: Conversion of alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their ratio. Am J Clin Nutr 84:44–53, 2006.
59. Liou YA, King DJ, Zibrik D, Innis SM: Decreasing linoleic acid with constant alpha-linolenic acid in dietary fats increases (n-3) eicosapentaenoic acid in plasma phospholipids in healthy men. J Nutr 137:945–952, 2007.
60. Ghosh S, Novak EM, Innis SM: Cardiac proinflammatory pathways are altered with different dietary n-6 linoleic to n-3 alpha-linolenic acid ratios in normal, fat-fed pigs. Am J Physiol Heart Circ Physiol 293:H2919–H2927, 2007.
61. Kobayashi M, Sasaki S, Kawabata T, Hasegawa K, Tsugane S: Validity of a self-administered food frequency questionnaire used in the 5-year follow-up survey of the JPHC Study Cohort I to assess fatty acid intake: comparison with dietary records and serum phospholipid level. J Epidemiol 13:S64–S81, 2003.
62. Kuriki K, Nagaya T, Tokudome Y, Imaeda N, Fujiwara N, Sato J, Goto C, Ikeda M, Maki S, Tajima K, Tokudome S: Plasma concentrations of (n-3) highly unsaturated fatty acids are good biomarkers of relative dietary fatty acid intakes: a cross-sectional study. J Nutr 133:3643–3650, 2003.
63. Dewailly E, Blanchet C, Gingras S, Lemieux S, Sauve L, Bergeron J, Holub BJ: Relations between n-3 fatty acid status and cardiovascular disease risk factors among Quebecers. Am J Clin Nutr 74:603–611, 2001.
64. Parkinson AJ, Cruz AL, Heyward WL, Bulkow LR, Hall D, Barstaed L, Connor WE: Elevated concentrations of plasma omega-3 polyunsaturated fatty acids among Alaskan Eskimos. Am J Clin Nutr 59:384–388, 1994.
65. Young KT, Gerrard JM, O’Neil JD: Plasma phospholipid fatty acids in the central Canadian Artic: biocultural explanations for ethnic differences. Am J Phys Anthropol 109:9–18, 1999.
66. Innis SM, Kuhnlein HV, Kinloch D: The composition of red cell membrane phospholipids in Canadian Inuit consuming a diet high in marine mammals. Lipids 23:1064–1068, 1988.
67. Amin AA, Menon RA, Reid KJ, Harris WS, Spertus JA: Acute coronary syndrome patients with depression have low blood cell membrane omega-3 fatty acid levels. Psychosom Med 70:856-862, 2008.
68. Su KP, Huang SY, Chiu CC, Shen WW: Omega-3 fatty acids in major depressive disorder: a preliminary double-blind, placebocontrolled trial. Eur Neuropsychopharmacol 13:267–271, 2003.
69. Green P, Hermesh H, Monselise A, Marom S, Presburger G, Weizman A: Red cell membrane omega-3 fatty acids are decreased in nondepressed patients with social anxiety disorder. Eur Neuropsychopharmacol 16:107–113, 2006.
70. Bijl RV, de Graaf R, Hiripi E, Kessler RC, Kohn R, Offord DR, Ustun TB, Vicente B, Vollebergh WA, Walters EE, Wittchen HU: The prevalence of treated and untreated mental disorders in five countries. Health Aff (Millwood) 22:122–133, 2003.
71. Martinez M: Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 120:S129–S138, 1992.
72. Haag M: Essential fatty acids and the brain. Can J Psychiatry 48:195–203, 2003.